As of April 2026, the FDA announced removal of injectable GHK-Cu from the Category 2 restricted list, with formal implementation expected July 2026
CJC-1295 is supplied as a lyophilized (freeze-dried) powder in a sterile glass vial sealed with a rubber stopper
Safety and efficacy of desogestrel/ethinyl estradiol and ethinyl estradiol tablets have been established in women of reproductive age
they are generally avoided in people with personal or family history of medullary thyroid carcinoma or MEN2
Trackers for weight, activity and food to identify trends and provide a roadmap for future success
We also wish to thank Peter Ravn (MedImmune Ltd, Cambridge, UK) for intellectual input into GLP-1 analogue peptide stabilization, Bojana Popovic and Daniel Cannon (MedImmune Ltd, Cambridge, UK) for generating and analysing the peptide homology model, Adrian Podmore (MedImmune Ltd, Cambridge, UK) for conducting the aggregation and stability testing, Richard Kay (LGC, Fordham, UK) for conducting the mass spectrometry metabolites identification work, Marcella Petrone and John Hood (MedImmune Ltd, Cambridge, UK) for performing PK-PD simulations and analysis as well as Christopher Rhodes (MedImmune LLC, Gaithersburg, MD, USA) for his critical review of this manuscript
